Picture of Dice Therapeutics logo

DICE — Dice Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid Cap

Brief: Lilly To Acquire Dice Therapeutics To Advance Innovation In Immunology

June 20 (Reuters) - Dice Therapeutics Inc  DICE.O :
    * LILLY TO ACQUIRE DICE THERAPEUTICS TO ADVANCE INNOVATION
IN
IMMUNOLOGY
    * DICE THERAPEUTICS INC - LILLY WILL COMMENCE A TENDER OFFER
TO
ACQUIRE ALL OUTSTANDING SHARES OF DICE FOR A PURCHASE PRICE OF
$48 PER SHARE IN CASH
    * DICE THERAPEUTICS INC - PROPOSED DEAL FOR AGGREGATE OF
APPROXIMATELY $2.4 BILLION
    * DICE THERAPEUTICS INC - TRANSACTION IS NOT SUBJECT TO ANY
FINANCING CONDITION

Source text for Eikon:  ID:nPn88JNZPa 
Further company coverage:  DICE.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Dice Therapeutics

See all news